human
influenza
pandem
last
year
caus
hi
subtyp
influenza
virus
recent
avian
influenza
virus
found
directli
infect
human
avian
host
recent
emerg
host
expans
spread
highli
pathogen
avian
influenza
hpai
subtyp
asia
heighten
concern
global
regard
mortal
hpai
human
potenti
new
pandem
respons
mani
agenc
organ
work
collabor
develop
earli
detect
system
prepared
plan
object
research
result
larg
influx
publish
inform
regard
potenti
risk
surveil
prevent
control
highli
pathogen
avian
influenza
particularli
regard
anim
human
subsequ
human
human
transmiss
chapter
review
current
human
infect
avian
influenza
public
health
medic
implic
human
influenza
pandem
last
year
caus
hi
subtyp
influenza
virus
recent
avian
influenza
virus
found
directli
infect
human
avian
host
recent
emerg
host
expans
spread
highli
pathogen
avian
influenza
hpai
subtyp
asia
heighten
concern
global
regard
mortal
hpai
human
potenti
new
pandem
respons
mani
agenc
organ
work
collabor
develop
earli
detect
system
prepared
plan
object
research
result
larg
influx
publish
inform
regard
potenti
risk
surveil
prevent
control
highli
pathogen
avian
influenza
particularli
regard
anim
human
subsequ
human
human
transmiss
chapter
review
current
human
infect
avian
influenza
public
health
medic
implic
influenza
b
c
import
genera
thorni
xovirida
famili
influenza
respons
human
pandem
outbreak
season
epidem
influenza
b
respons
increas
case
season
diseas
influenza
virus
envelop
singlestrand
rna
virus
segment
genom
eight
rna
segment
genom
encod
viral
protein
includ
polymeras
protein
fbi
matrix
protein
ml
surfac
glycoprotien
hemagglutinin
ha
neuraminidas
na
influenza
virus
classifi
subtyp
basi
antigen
properti
hemagglutinin
neuraminidas
glycoprotein
express
surfac
virion
date
hemagglutinin
neuraminidas
subtyp
identifi
found
differ
combin
eg
hlnl
etc
hemagglutinin
glycoprotein
mediat
attach
entri
viru
bind
sialic
acid
receptor
cell
surfac
bind
affin
hemagglutinin
host
sialic
acid
allow
host
specif
influenza
specif
avian
influenza
subtyp
prefer
bind
sialic
acid
link
galactos
linkag
found
duck
intestin
epithelium
poultri
duck
respiratori
epithelium
human
viru
subtyp
hi
bind
linkag
found
human
respiratori
epithelium
swine
contain
linkag
respiratori
epithelium
allow
easi
coinfect
human
avian
subtyp
reason
cite
hkeli
genesi
novel
strain
human
pandem
given
pig
design
mix
vessel
new
strain
lesser
degre
human
found
contain
unkag
lower
respiratori
tract
conjunctiva
allow
human
infect
avian
strain
hemagglutinin
glycoprotein
main
target
immun
neutral
antibodi
neuraminidas
glycoprotein
allow
spread
viru
cleav
glycosid
linkag
sialic
acid
host
cell
surfac
viru
viru
spread
secret
bodili
fluid
neuraminidas
glycoprotein
lesser
target
immun
neutrahz
antibodi
target
site
antivir
neuraminidas
inhibitor
addit
hemagglutinin
neuraminidas
classif
influenza
virus
character
pathogen
highli
pathogen
avian
influenza
hpai
defin
world
organ
anim
health
oie
influenza
caus
sever
diseas
death
domest
poultri
hpai
virus
except
subtyp
subtyp
hpai
virus
potenti
pathogen
subtyp
evalu
sequenc
hemagglutinin
gene
sinc
pathogen
associ
presenc
multipl
basic
amino
acid
hemagglutinin
cleavag
site
chang
low
pathogen
subtyp
highli
pathogen
form
may
occur
upon
introduct
poultri
thought
occur
primarili
result
insert
basic
amino
acid
hemagglutinin
cleavag
site
molecular
studi
shown
human
pandem
hlnl
subtyp
origin
low
pathogen
avian
viru
contrast
current
human
case
worldwid
result
highli
pathogen
avian
influenza
viru
influenza
virus
highli
variabl
result
molecular
chang
rna
segment
occur
number
mechan
import
point
mutat
antigen
drift
rna
segment
reassort
antigen
shift
like
rna
virus
influenza
virus
lack
proofread
abil
therefor
subject
point
mutat
individu
mutat
viral
genom
caus
minor
chang
antigen
charact
viru
amino
acid
chang
hemagglutinin
neuraminidas
princip
import
reassort
occur
host
cell
infect
two
influenza
virus
lead
creation
novel
subtyp
contain
new
hemagglutinin
neuraminidas
immunolog
distinct
previou
circul
strain
seen
pig
possess
receptor
human
avian
subtyp
three
major
pandem
occur
last
centuri
hlnl
reassort
howev
point
mutat
lead
viral
adapt
human
host
occur
avian
influenza
subtyp
influenza
virus
infect
wide
rang
host
includ
mani
avian
speci
variou
mammalian
speci
swine
ferret
felid
mink
whale
hors
seal
dog
civet
human
wild
bird
duck
gees
swan
shorebird
import
natur
reservoir
virus
known
hemagglutinin
neuraminidas
subtyp
found
bird
case
subtyp
found
within
gastrointestin
tract
bird
shed
fece
rare
caus
diseas
sinc
howev
hpai
virus
origin
asia
report
approxim
wild
bird
speci
caus
diseas
instanc
asymptomat
shed
other
viru
spread
across
asia
europ
middl
east
african
countri
addit
speci
tiger
leopard
cat
stone
marten
human
also
becom
infect
hpai
wide
host
rang
mani
bird
speci
may
one
potenti
mechan
spread
hpai
worldwid
thu
complic
potenti
contact
transmiss
mutabl
hpai
anim
human
popul
incid
avian
influenza
infect
human
increas
last
decad
tabl
ii
initi
case
avian
influenza
human
occur
associ
poultri
outbreak
manifest
selflimit
conjunct
larg
scale
hpai
outbreak
occur
among
poultri
hong
kong
document
human
case
fecalor
respiratori
rout
among
wild
bird
poultri
human
interact
infect
secret
bird
major
mode
transmiss
contact
includ
consumpt
undercook
raw
poultri
product
handl
sick
dead
bird
without
protect
food
process
bird
clean
site
bird
domest
poultri
waterfowl
transmiss
wild
bird
contamin
water
report
case
limit
human
human
transmiss
report
among
health
care
worker
famili
member
tabl
case
person
protect
equip
util
major
factor
transmiss
human
clinic
manifest
avian
influenza
human
rang
mild
conjunct
sever
pneumonia
multipl
organ
failur
mof
age
patient
vari
major
case
hpai
outbreak
young
median
age
case
year
case
southeast
asia
median
age
rang
month
year
nearli
case
link
sick
infect
poultri
incub
period
rang
day
contact
symptom
symptom
outbreak
vari
avian
influenza
subtyp
netherland
outbreak
subtyp
present
conjunct
case
canada
uk
also
present
conjunct
howev
hpai
hong
kong
case
influenzalik
ill
case
pneumonia
develop
progress
mof
acut
respiratori
distress
syndrom
ard
death
rey
syndrom
pulmonari
hemorrhag
predomin
nausea
vomit
diarrhea
complic
case
case
worldwid
outbreak
origin
southeast
asia
similar
present
hpai
case
main
present
symptom
pneumonia
fever
influenzalik
ill
diarrhea
present
case
mani
case
thrombocytopenia
lymphopenia
chest
radiograph
find
includ
interstiti
infiltr
lobar
consolid
air
bronchogram
sixtyeight
percent
patient
develop
ard
mof
within
day
diseas
onset
case
fatahti
rate
rang
depend
case
seri
case
reach
critic
care
unit
howev
mortal
averag
time
death
diseas
onset
day
postmortem
studi
illustr
find
consist
mof
overwhelm
system
inflammatori
respons
syndrom
sir
includ
diffus
alveolar
damag
acut
tubular
necrosi
atrophi
dissemin
intravascular
coagul
dig
multiorgan
damag
interestingli
viru
isol
lung
intestin
spleen
brain
suggest
viremia
howev
activ
replic
viru
limit
lung
overwhelm
inflammatori
respons
acut
lung
injuri
ali
ard
predomin
featur
coincid
find
preferenti
bind
avian
influenza
virus
linkag
type
ii
pneumocyt
lower
respiratori
tract
human
subsequ
viral
replic
cytokin
releas
overwhelm
host
immun
respons
subsequ
system
manifest
occur
clinic
diagnosi
avian
influenza
infect
human
difficult
reli
epidemiolog
link
endem
area
contact
sick
dead
poultri
contact
confirm
case
avian
influenza
sinc
mani
infecti
diseas
present
find
featur
signific
clinician
may
contact
endem
area
travel
infect
poultri
clinician
alway
elicit
detail
histori
definit
diagnosi
made
isol
viru
cultur
clinic
specimen
method
provid
definit
diagnosi
viral
isol
avail
test
includ
pathogen
antivir
resist
dna
sequenc
analysi
altern
antibodi
test
perform
standard
fourfold
titer
increas
specif
subtyp
avian
influenza
viru
neutral
antibodi
titer
assay
perform
microneutralizaiton
techniqu
western
blot
analysi
recombin
confirmatori
test
posit
microneutr
assay
recent
rapid
diagnosi
perform
revers
transcriptionpolymeras
chain
reaction
clinic
sampl
primer
specif
viral
subtyp
test
perform
patient
meet
case
definit
indirect
immunofloresc
enzym
immunoassay
test
confirm
influenza
suspect
case
avian
influenza
human
investig
public
health
offici
provinc
countri
origin
addit
government
laboratori
often
equip
appropri
biolevel
safeti
laboratori
primer
librari
associ
expertis
confirm
diagnosi
quickli
effici
clinic
specimen
submit
assist
public
health
expert
treatment
avian
influenza
infect
human
includ
antivir
therapi
support
care
adjunct
therapi
control
chnical
trial
efficaci
antivir
neuraminidas
inhibitor
support
therapi
adjuv
care
never
perform
current
recommend
stem
experi
past
avian
influenza
outbreak
anim
model
adamantan
rimantadin
amantadin
neuraminidas
inhibitor
oseltamivir
zanamivir
antivir
use
treatment
prophylaxi
influenza
infect
human
adamantan
bind
protein
viral
capsul
inhibit
dissoci
matrix
protein
nucleocapsid
viral
uncoat
avian
influenza
viru
infect
adamantan
role
due
widespread
resist
hpai
isol
southeast
asia
carri
mutat
confer
resist
group
antivir
fact
isol
hi
human
subtyp
season
influenza
resist
adamantan
therebi
limit
use
season
epidem
human
subtyp
role
limit
prophylaxi
commun
circul
strain
known
suscept
adamantan
neuraminidas
inhibitor
oseltamivir
zanamivir
extens
studi
treatment
prophylaxi
human
influenza
subtyp
hi
well
influenza
b
avian
influenza
efficaci
well
document
anim
model
improv
surviv
seen
infect
hpai
time
treatment
paramount
earlier
therapi
directli
relat
improv
surviv
greatest
level
protect
seen
neuraminidas
inhibitor
start
within
hour
infect
protect
rapidli
drop
hour
hpai
case
southeast
asia
surviv
appear
improv
patient
receiv
oseltamavir
earlier
day
compar
day
time
much
longer
document
anim
model
window
optim
therapi
larg
unknown
addit
therapi
oseltamivir
shown
decreas
viral
level
nasal
secret
patient
infect
hpai
oseltamavir
therapi
mg
twice
daili
mg
daili
reserv
prophylaxi
drug
oral
bioavafl
reach
signific
plasma
broncho
alveolar
line
fluid
level
zanamivir
avail
dri
powder
inhal
mg
twice
daili
treatment
mg
daili
prophylaxi
zanamivir
use
human
avian
influenza
case
concern
exist
treatment
inhal
powder
plasma
level
significantli
lower
oseltamivir
neuraminidas
inhibitor
resist
document
hpai
subtyp
vietnames
girl
treat
mg
daili
day
postexposur
prophylaxi
na
glycoprotein
histadin
tyrosin
substitut
posit
convey
markedli
higher
ic
oseltamivir
zanamivir
resist
found
chang
neuraminidas
resist
document
hpai
case
date
combin
therapi
studi
influenza
virus
ribaviron
inhal
evalu
vitro
avian
influenza
subtyp
found
reduc
mortal
influenza
b
mous
model
anim
model
studi
indic
determin
role
ribaviron
combin
therapi
avian
influenza
virus
support
care
iv
rehydr
mechan
ventil
vasopressor
therapi
renal
replac
therapi
requir
mof
ard
featur
diseas
due
progress
pneumonia
ard
noninvas
ventil
recommend
earli
intub
may
benefici
overt
respiratori
failur
ensu
corticosteroid
use
patient
hpai
definit
role
steroid
determin
immunomodulatori
therapi
report
human
vaccin
avian
influenza
virus
wide
use
although
multipl
vaccin
trial
underway
prior
avian
vaccin
human
poorli
immunogen
thu
limit
use
inactiv
test
toler
hmite
immunogen
vaccin
develop
neutral
antibodi
limit
degre
recent
larg
random
trial
look
attenu
vaccin
vietnam
strain
modest
immunolog
respons
seen
microneutr
antibodi
develop
time
dose
season
influenza
side
effect
minim
number
industri
trial
adjuv
vaccin
current
ongo
sandofiadventi
recent
report
success
attenu
vaccin
low
dose
result
releas
thu
far
although
promis
human
vaccin
avian
influenza
virus
still
develop
underscor
develop
uncertainti
pandem
strain
may
vastli
differ
antigen
properti
develop
vaccin
health
care
infect
control
crucial
compon
manag
avian
influenza
infect
new
pandem
strain
experi
sever
acut
respiratori
syndrom
sar
outbreak
illustr
appropri
infect
control
measur
paramount
reduc
spread
health
care
worker
possibl
commun
therefor
world
health
organ
center
diseas
control
prevent
cdc
recommend
contact
airborn
precaut
initi
suspect
case
avian
influenza
human
late
octob
cdc
releas
updat
interim
guidanc
use
mask
respir
health
care
set
tabl
certain
high
risk
procedur
addit
protect
particul
respir
may
consid
given
likelihood
gener
aerosol
particl
may
enhanc
transmiss
tabl
respiratori
protect
worn
along
imperm
gown
face
shield
glove
initi
case
place
neg
pressur
isol
room
air
chang
per
hour
hand
hygien
antibacteri
soap
alcohol
base
washless
gel
standard
appropri
basin
patient
room
season
vaccin
health
care
worker
preform
emphas
reduc
spread
visitor
famili
member
strictli
monitor
limit
reduc
likelihood
spread
final
antivir
chemoprophylaxi
avail
health
care
worker
exposur
infect
individu
symptomat
worker
taken
duti
workplac
surveil
occur
aggress
measur
risk
health
care
worker
patient
famili
member
reduc
avian
influenza
virus
occur
increas
incid
within
human
popul
reflect
delic
tangl
interact
wildlif
domest
anim
human
diseas
human
limit
conjunct
influenzalik
ill
hpai
caus
mainli
sever
pneumonia
respiratori
failur
death
case
occur
direct
transmiss
infect
poultri
waterfowl
limit
case
human
human
transmiss
treatment
success
neuraminidas
inhibitor
start
earli
vaccin
develop
underway
immunogen
attenu
viru
prepar
infect
control
measur
mainstay
prevent
diseas
reduct
avian
influenza
virus
may
constitut
part
next
pandem
appropri
knowledg
prevent
treatment
reduc
likelihood
occurr
